TRIASTEK INC has a total of 52 patent applications. It increased the IP activity by 440.0%. Its first patent ever was published in 2016. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets machines, pharmaceuticals and medical technology are Aprecia Pharmaceuticals LLC, APRECIA PHARMACEUTICALS CO and BLAESI ARON H.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | WIPO (World Intellectual Property Organization) | 8 | |
#3 | Australia | 6 | |
#4 | Canada | 6 | |
#5 | EPO (European Patent Office) | 6 | |
#6 | Republic of Korea | 6 | |
#7 | China | 5 | |
#8 | Singapore | 2 | |
#9 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Machines | |
#2 | Pharmaceuticals | |
#3 | Medical technology | |
#4 | Organic fine chemistry | |
#5 | Basic materials chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Additive manufacturing | |
#3 | Shaping of plastics | |
#4 | Fillers | |
#5 | Medical purpose containers | |
#6 | Certain plastics | |
#7 | Therapeutic chemical compounds | |
#8 | Syringes | |
#9 | Specific use of cosmetics | |
#10 | Preservation of human bodies |
# | Name | Total Patents |
---|---|---|
#1 | Li Xiaoling | 52 |
#2 | Cheng Senping | 35 |
#3 | Deng Feihuang | 32 |
#4 | Liu Haili | 17 |
#5 | Wu Wei | 17 |
#6 | Lu Haohui | 16 |
#7 | Yao Juan | 11 |
#8 | Li Renjie | 8 |
#9 | Liu Yang | 7 |
#10 | Wang Xiaofei | 6 |
Publication | Filing date | Title |
---|---|---|
WO2021031824A1 | High-throughput and high-preciscion pharmaceutical additive manufacturing system | |
WO2021042865A1 | Oral drug dosage forms having a desired pk profile and methods of designing and producing thereof | |
CN111698983A | Compound oral pharmaceutical dosage form comprising fixed doses of an ADHD non-stimulant and an ADHD stimulant | |
US2019209468A1 | Dosage forms with desired release profiles and methods of designing and making thereof | |
AU2018267821A1 | 3D printing device and method | |
US10201503B1 | Precision pharmaceutical 3D printing device | |
CA3051614A1 | Dosage forms of controlled release at specific gastrointestinal sites | |
EP3452003A1 | Controlled release dosage form | |
KR20180014778A | Formulations and uses thereof | |
CN106236715A | Pharmaceutical formulation and use thereof |